aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with a mission to streamline and enhance nurse navigation programs, Nursenav offers specialized software designed to provide consistent and measurable standards of care. The company's core product, Nursenav Oncology, is a digital platform and mobile application that empowers patient navigators and community health workers. By focusing on oncology navigation, the software aims to improve patient outcomes and operational efficiency within healthcare facilities.
Nursenav has garnered attention for its innovative approach to patient navigation, attracting notable healthcare professionals and investors committed to improving patient care. Key achievements include the successful implementation of their software in various healthcare settings, leading to enhanced patient management and satisfaction. Overall, Nursenav's impact lies in its ability to provide healthcare facilities with a competitive advantage through improved care coordination and patient support.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Navigation Software
Technology
Software
Tags
SaaS
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Nursenav founded?
Nursenav was founded in 2007.
Where is Nursenav’s headquarters located?
Nursenav’s headquarters is located in North Charleston, US.
When was Nursenav’s last funding round?
Nursenav’s most recent funding round was for $372.9k (USD) in December 2009.
How many employees does Nursenav have?
Nursenav has 5 employees as of Feb 5, 2024.
How much has Nursenav raised to-date?
As of July 05, 2023, Nursenav has raised a total of $372.9k (USD) since Dec 16, 2009.
Add Comparison
Total Raised to Date
$372.9k
USD
Last Update Dec 16, 2009
Last Deal Details
$372.9k
USD
Dec 16, 2009
Series Unknown
Total Employees Over Time
5
As of Feb 2024
Nursenav Address
8420 Dorchester Rd
suite 102
North Charleston,
29420
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts